HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Crawford Pleads Guilty Of Failing To Disclose Stocks In Firms FDA Regulates

This article was originally published in The Tan Sheet

Executive Summary

Former FDA Commissioner Lester Crawford on Oct. 17 pleaded guilty in federal court to charges related to owning stocks in companies regulated by the agency

You may also be interested in...



People In Brief

Perrigo promotes in pricing, planning

FDA Commissioner Search Should Adopt Team Approach – Stakeholders

The Obama administration's search for FDA's next leader should center on finding a team of qualified people - rather than just a single commissioner - to head the agency, former FDA officials and industry executives say

Von Eschenbach Resigning In January With BTC Debate In His Legacy

FDA Commissioner Andrew von Eschenbach will return to Texas upon resigning his post Jan. 20, leaving a legacy that includes restarting discussions on whether a third class of drugs is needed

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS125249

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel